COronaVirus Induced Acute Respiratory Disease Syndrome During PREGnancy
NCT ID: NCT05193526
Last Updated: 2023-09-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2021-11-15
2023-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Two strategies will be compared on maternal, obstetric and neonatal outcomes:
* Wait strategy defined by no extraction within 24 hours of invasive venting
* Early strategy defined by extraction within 24 hours of invasive ventin
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Obstetric and Perinatal Outcomes of Women With COVID-19
NCT04369859
Clinical Study of Pregnant Women With COVID-19
NCT04701944
Post-intensive Care Syndromes in Pregnant Patients With Respiratory Failure and COVID-19 Compared to Non-pregnant Patients With Respiratory Failure and COVID-19
NCT07051967
Parvovirus B19 Infection in Pregnancy: Clinical Manifestations and Fetus/Newborn Outcome
NCT07338279
Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy
NCT04319016
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
No intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Intercommunal Creteil
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frederique SCHORTGEN, PhD
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Intercommunal Créteil
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
40 Avenue de Verdun
Créteil, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Schortgen F, Tabra Osorio C, Demiri S, Dzogang C, Jung C, Lavenu A, Lecarpentier E; COVADIS-PREG study group. Management of pregnant women in tertiary maternity hospitals in the Paris area referred to the intensive care unit for acute hypoxaemic respiratory failure related to SARS-CoV-2: which practices for which outcomes? Ann Intensive Care. 2024 Jun 18;14(1):94. doi: 10.1186/s13613-024-01313-2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COVADIS PREG
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.